This page was last updated on 12/20/2023. Please check back frequently for updates.

The American Society of Clinical Oncology (ASCO) Survey on COVID-19 in Oncology Registry (ASCO Registry) is currently closed for all data entry.  Please see below for several resources developed using the data.  The Registry collected data about patients undergoing cancer treatment who have a confirmed prior or current COVID-19 infection. Specifically, the registry collected data about patients with cancer and patients who are cancer-free receiving adjuvant cancer therapy within a year of cancer surgery, including patients receiving hormone-only adjuvant therapy and patients receiving supportive care only. The ASCO Registry was designed to collect both baseline and follow-up data on how the virus impacts cancer care and cancer patient outcomes during the COVID-19 pandemic and into 2023.

ASCO provides deidentified ASCO Registry data for research purposes to qualified individuals and organizations. Information on the process to submit a proposed research study is available at the Data Library link below.

ASCO Registry Resources

View the COVID-19 Data Dashboard    View the COVID-19 Registry Data Map   
 

Request the COVID-19 Registry Data in ASCO’s Data Library
 

Study Information

• ASCO Registry Study Schema
• Institutional Review Board (IRB) Exemption Letter

ASCO Publications

• Manuscript: Dr. Dax Kurbegov, et al., Rate of COVID‐19 vaccination among patients with cancer who tested positive for severe acute respiratory syndrome‐coronavirus 2: Analysis of the American Society of Clinical Oncology Registry - Kurbegov - Cancer - Wiley Online Library
• Abstract: Breakthrough COVID-19 cases and hospitalization risk: ASCO COVID-19 registry. | Journal of Clinical Oncology (ascopubs.org) 
• Abstract: COVID-19 vaccine uptake in patients with cancer and Sars-Cov-2 infection in 2020: Results from the ASCO registry. | Journal of Clinical Oncology (ascopubs.org) 
• Manuscript: Dr. Kathryn F. Mileham et al., Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO Registry | JCO Oncology Practice (ascopubs.org) 
• Abstract: Dr. Kathryn F. Mileham et al., Mortality risk for patients undergoing cancer treatment who acquire SARS-CoV-2: ASCO registry. | Journal of Clinical Oncology (ascopubs.org)
  
  • Poster - Program Guide – ASCO Meeting Program Guide

ASCO Research Grants

• Conquer Cancer names inaugural recipients of ASCO Registry Research Grants
• ASCO Registry Melanoma Research Grant

Grantee Publications

• Manuscript: Dr. Adana A.M. Llanos et al., Evaluation of Inequities in Cancer Treatment Delay or Discontinuation Following SARS-CoV-2 Infection
• Manuscript: Dr. Samyukta Mullangi et al., Reexamining Social Determinants of Health Data Collection in the COVID-19 Era
• Manuscript: Dr. Samyukta Mullangi et al., Factors Associated With Cancer Treatment Delay Among Patients Diagnosed With COVID-19
• Abstract: Dr. Jessica Y. Islam et al., Racial/ethnic disparities of cancer treatment disruptions among patients with breast cancer with SARS-CoV-2 infection: An analysis of the ASCO Survey on COVID-19 in Oncology Registry. | Journal of Clinical Oncology (ascopubs.org) 
• Abstract: Dr. Jessica Y. Islam et al., The role of rurality in cancer treatment disruptions among patients with cancer diagnosed with SARS-CoV-2: An analysis of the ASCO Survey on COVID-19 in Oncology Registry. | Journal of Clinical Oncology (ascopubs.org)
• Abstract: Dr. Jessica Y. Islam et al., Disparities in cancer treatment delays or discontinuation among cancer patients diagnosed with SARS-CoV-2 infection: An analysis of the U.S. ASCO COVID-19 and cancer registry | Cancer Research | American Association for Cancer Research (aacrjournals.org)

Please contact the CENTRA team for additional information or questions.